title: Impact of pre-diabetes and diabetes on cardiovascular outcomes.
abstract: The present paper examines major evidences on the correlation between pre-diabetes, diabetes and cardiovascular risk, especially focusing on early and multifactorial treatment strategies holding the potential to delay the occurrence of micro- and macro-vascular complications causing impaired quality of life and reduced survival.
authors.affiliation: Division of Cardiology, Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy. matteo.anselmino@unito.it
authors.forename: Matteo
authors.initials: M
authors.lastname: Anselmino
authors.forename: Dario
authors.initials: D
authors.lastname: Sillano
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000209:etiology* / Q000401:mortality / Q000628:therapy; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D011236:Prediabetic State / Q000097:blood / Q000150:complications* / Q000401:mortality / Q000628:therapy; D015995:Prevalence; D011314:Preventive Health Services; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; C517652:hemoglobin A1c protein, human